简介：
Overview
This study investigates the effects of repetitive transcranial magnetic stimulation (rTMS) at different frequencies (1 Hz, 20 Hz, and 40 Hz) on the metabolism of amyloid-beta (Aβ) and tau proteins in the cerebrospinal fluid (CSF) of rhesus monkeys. The research utilizes a novel CSF sampling technique under fully awake conditions to assess changes in biomarker levels post-rTMS intervention.
Key Study Components
Area of Science
- Neuroscience
- Neurochemistry
- Transcranial magnetic stimulation
Background
- Repetitive transcranial magnetic stimulation (rTMS) is explored as a potential method to influence neurodegenerative biomarkers.
- Aβ and tau are critical in understanding Alzheimer's disease and related conditions.
- The study employs a pilot investigation, emphasizing a novel approach to CSF sampling.
- Research was conducted with a male rhesus monkey model, relevant for translational research in neurodegenerative studies.
Purpose of Study
- To assess the impact of varying rTMS frequencies on the levels of Aβ and tau in CSF.
- To validate the repeated CSF sampling method under awake conditions with minimal risk.
- To investigate potential biomarkers associated with cognitive function and neurodegeneration.
Methods Used
- The protocol employs serial cisterna magna CSF sampling.
- The biological model is a male rhesus monkey subjected to rTMS intervention.
- No multiomics workflows are highlighted in the methodology.
- Key steps include anaesthesia confirmation, catheterization, adaptive training, and rTMS application.
- CSF collection occurs at multiple time points following rTMS stimulation.
Main Results
- Post-stimulation, Aβ levels showed differential responses based on frequency, with significant increases noted after 1 Hz and 20 Hz interventions.
- tTau levels increased significantly after 20 Hz and 40 Hz stimulation.
- pTau levels exhibited a notable increase immediately post 40 Hz stimulation.
- No significant changes in tau levels were observed after 1 Hz stimulation.
Conclusions
- This study demonstrates the feasibility of using rTMS to modulate key neurodegenerative biomarkers in awake non-human primates.
- Findings enhance understanding of how rTMS can influence the metabolism of Aβ and tau, contributing valuable insights into therapeutic interventions for neurodegenerative diseases.
- The developed CSF sampling method may serve as an important tool for future studies on biomarker dynamics in primate models.
What are the advantages of the rTMS method used in this study?
The rTMS method allows non-invasive modulation of neural activity while monitoring changes in cerebrospinal fluid biomarkers under awake conditions, minimizing risk.
How is the CSF sampling conducted in this research?
CSF is sampled using a serial cisterna magna approach with an implanted catheter, allowing for multiple collections without anesthesia.
What biological data are obtained through this method?
The primary outcomes include changes in amyloid-beta and tau protein levels in the CSF, which are crucial for understanding neurodegenerative processes.
How can this method be adapted for other studies?
Researchers can modify the stimulation frequencies and biomarker targets to suit various neurobiological investigations in primate models.
What limitations should be considered with this approach?
While the method is safe, the specific impacts of rTMS on cognitive function in long-term studies remain to be elucidated.
What implications do these findings have for future research?
The findings could inform therapeutic strategies targeting neurodegenerative biomarkers and advance understanding of rTMS efficacy in clinical settings.
繁體中文
